|
Volumn 24, Issue 6, 2014, Pages 1472-1478
|
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease
|
Author keywords
Amyloid; Dementia; Disease modifying; Excitotoxicity; Glutamate; Multi target directed ligands; Multifunctional compounds; Neurodegeneration; Neuroprotection; Nicotinic
|
Indexed keywords
COTININE;
DONEPEZIL;
GALANTAMINE;
MEMANTINE;
NEUROPROTECTIVE AGENT;
NICOTINE DERIVATIVE;
RIVASTIGMINE;
ALZHEIMER DISEASE;
ANIMAL CELL;
ARTICLE;
CELL VIABILITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG SCREENING;
NEUROPROTECTION;
NONHUMAN;
RAT;
STEREOISOMERISM;
STRUCTURE ACTIVITY RELATION;
AMYLOID;
DEMENTIA;
DISEASE MODIFYING;
EXCITOTOXICITY;
GLUTAMATE;
MULTI-TARGET-DIRECTED LIGANDS;
MULTIFUNCTIONAL COMPOUNDS;
NEURODEGENERATION;
NEUROPROTECTION;
NICOTINIC;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
ANIMALS;
CELL SURVIVAL;
CELLS, CULTURED;
COTININE;
HUMANS;
NEURONS;
NEUROPROTECTIVE AGENTS;
NICOTINE;
PEPTIDE FRAGMENTS;
RATS;
RECEPTORS, N-METHYL-D-ASPARTATE;
|
EID: 84895816602
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2014.02.008 Document Type: Article |
Times cited : (50)
|
References (35)
|